XCUR
Exicure, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.25
+1.63%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-847.9%
Return on equity
-72.7%
Return on assets
-747.6%
Return on invested capital
0.00x
Asset turnover
-$6.7M
Cash from operations
$0.26
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026